Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 13 & 14

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Jan 20, 2021 5:20pm

101 Views

Post# 32340329

RE:RE:RE:13 & 14

Agree...

In terms of the "9 month" data, I referenced that point in time simply from a scientific/PI perspective...it wouldn't be reported, but it certainly would be a good early indicator of protocol success in the event there isn't a high "early" CR rate. With a limited budget, I honestly hope they make significantly more progress on this trial & with the Covid-19 study (& also see Roswell play out) before taking on GBM.

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!